BridgeBio Pharma
BBIO
BBIO
243 hedge funds and large institutions have $5.42B invested in BridgeBio Pharma in 2024 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 99 increasing their positions, 81 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
3.1% less ownership
Funds ownership: 96.21% → 93.11% (-3.1%)
7% less funds holding in top 10
Funds holding in top 10: 15 → 14 (-1)
20% less capital invested
Capital invested by funds: $6.76B → $5.42B (-$1.34B)
Holders
243
Holding in Top 10
14
Calls
$266M
Puts
$95.3M
Top Buyers
| 1 | +$67.1M | |
| 2 | +$34.4M | |
| 3 | +$21.3M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
+$18.2M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$13.9M |
Top Sellers
| 1 | -$66.1M | |
| 2 | -$50.7M | |
| 3 | -$17.8M | |
| 4 |
D.E. Shaw & Co
New York
|
-$15.7M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$11.4M |